US Stock Movement: Heartflow surged on October 20 as target price was raised, buy rating given, and AI cardiovascular diagnostics highlighted
Bitget异动解读2026/10/20 19:24Heartflow October 20 Significant Increase Analysis
Keywords: Target Price Upgrade, Buy Rating, AI Cardiovascular Diagnosis
Date not specified, Piper Sandler maintains a Buy rating on Heartflow and has raised the target price from $45 to $64.
(Disclaimer: This content is generated by AI technology summarizing publicly available information for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%
Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.
Crypto prices
More
